Optimisation of cosolvent concentration for topical drug delivery III - Influence of lipophilic vehicles on ibuprofen permeation

Skin Pharmacology and Physiology

Volumn 24, Issue 1, 2010, Pages 22-26

  Watkinson, R M ^a   Guy, R H ^b   Oliveira, G ^c   Hadgraft, J ^c   Lane, M E ^c  

^a Aesop   (Australia)

^b University of Bath   (United Kingdom)

^c UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Ibuprofen; Miglyol 812; Mineral oil; Permeation; Silicone

Indexed keywords

ALCOHOL; IBUPROFEN; MIGLYOL; MINERAL OIL; PROPYLENE GLYCOL; SILICONE; WATER;

ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG PENETRATION; DRUG SOLUBILITY; DRUG TRANSPORT; DRUG UPTAKE; HUMAN; HYDROPHILICITY; LIPOPHILICITY; OUTCOME ASSESSMENT; PHASE PARTITIONING; PRIORITY JOURNAL; SKIN PERMEABILITY;

ADMINISTRATION, CUTANEOUS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DRUG DELIVERY SYSTEMS; HUMANS; IBUPROFEN; MEMBRANES, ARTIFICIAL; MINERAL OIL; PERMEABILITY; SILICONES; SKIN; SKIN ABSORPTION; SOLUBILITY; SOLVENTS; THERMODYNAMICS; TRIGLYCERIDES;

EID: 77954307697     PISSN: 16605527     EISSN: None     Source Type: Journal    
DOI: 10.1159/000315139     Document Type: Article

References (22)

1. Wotton PK, Mollgaard B, Hadgraft J, Hoelgaard A: Vehicle effect on topical drug delivery. III. Effect of azone on the cutaneous permeation of metronidazole and propylene glycol. Int J Pharm 1985; 24: 19-26.
2. Trottet L, Merly C, Mirza M, Hadgraft J, Davis AF: Effect of finite doses of propylene glycol on enhancement of in vitro percutaneous permeation of loperamide hydrochloride. Int J Pharm 2004; 274: 213-219.
3. Otto A, Wiechers JW, Kelly CL, Hadgraft J, du Plessis J: Effect of penetration modifiers on the dermal and transdermal delivery of drugs and cosmetic active ingredients. Skin Pharmacol Physiol 2008; 21: 326-334.
4. Watkinson RM, Herkenne C, Guy RH, Hadgraft J, Oliveira G, Lane ME: Influence of ethanol on the solubility, ionisation and permeatio characteristics of ibuprofen in silicone and human skin. Skin Pharmacol Physiol 2009; 22: 15-21.
5. Watkinson RM, Guy RH, Hadgraft J, Lane ME: Optimisation of cosolvent concentration for topical drug delivery. II. Influence of propylene glycol on ibuprofen permeation. Skin Pharmacol Physiol 2009; 22: 225-230.
6. Abramowitz R, O'Donoghue D: Mineral oil, light; in Rowe RC, Sheskey PJ, Weller PJ (eds): Handbook of Pharmaceutical Excipients, ed 4. Washington, Pharmaceutical Press and American Pharmaceutical Association, 2003, pp 398-399.
7. Tranner F, Berube G: Mineral oil and petrolatum - reliable moisturizers. Cosmet Toiletries 1978; 93: 81.
8. Roberts MS, Anderson RA: The percutaneous absorption of phenolic compounds: the effect of vehicle on the penetration of phenol. J Pharm Pharmacol 1975; 27: 599-605.
9. Evans JR, Hughes C: In vitro methodology for investigating quantitative relationships between skin permeation and compound structure. J Pharm Pharmacol 1986; 38: 68P.
10. Backhouse L, Dias M, Gorce JP, Hadgraft J, McDonald PJ, Wiechers JW: GARField magnetic resonance profiling of the ingress of model skin-care product ingredients into human skin in vitro. J Pharm Sci 2004; 93: 2274-2283.
11. Iannuccelli V, Coppi G, Sergi G, Mezzena M, Scalia S: In vivo and in vitro skin permeation of butyl methoxydibenzoylmethane from lipospheres. Skin Pharmacol Physiol 2008; 21: 30-38.
12. Pouton CW, Porter CJH: Formulation of lipid- based delivery systems for oral administration: materials, methods and strategies. Adv Drug Deliv Rev 2008; 60: 625-637.
13. Cornwell PA, Tubek J, van Gompel HAHP, Little CJ, Wiechers JW: Glyceryl monocaprylate/ caprate as a moderate skin penetration enhancer. Int J Pharm 1998; 171: 243-251.
14. Hansen CM: Hansen Solubility Parameters. A User's Handbook. Boca Raton, CRC Press, 2000.
15. Diez-Sales O, Watkinson AC, Herraez- Dominguez M, Javaloyes C, Hadgraft J: A mechanistic investigation of the in vitro human skin permeation enhancing effect of Azone. Int J Pharm 1996; 129: 33-40.
16. Bustamante P, Pena MA, Barra J: The modified extended Hansen method to determine partial solubility parameters of drugs containing a single hydrogen bonding group and their sodium derivatives: benzoic acid/Na and ibuprofen/Na. Int J Pharm 2000; 194: 117-124.
17. Most CF: Co-permeant enhancement of drug transmission rates through silicone rubber. J Biomed Mater Res 1972; 6: 3-14.
18. Liron Z, Cohen S: Percutaneous absorption of alkanoic acids. I. A study of operational conditions. J Pharm Sci 1984; 73: 534-537. (Pubitemid 14134334)
19. Ginoz S, Rey S, Boss G, Bunge AL, Guy RH, Carrupt P-A, Reist M, Testa B: Quantitative structure-permeation relationships for solute transport across silicone membranes. Pharm Res 2002; 19: 1622-1629.
20. Wasdo SC, Juntunen J, Devarajan H, Sloan KB: A correlation of flux through a silicone membrane with flux through hairless mouse skin and human skin in vitro. Int J Pharm 2009; 373: 62-67.
21. Iervolino M, Cappello B, Raghavan SL, Hadgraft J: Penetration enhancement of ibuprofen from supersaturated solutions through human skin. Int J Pharm 2001; 212: 131-141.
22. Kessner D, Ruettinger A, Kiselev MA, Wartewig S, Neubert RHH: Properties of ceramides and their impact on the stratum corneum structure: a review. Part 2: stratum corneum lipid model systems. Skin Pharmacol Physiol 2008;21:58-74.